• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用分子动力学模拟和 MM-PBSA 解释源自 p25 的肽对周期蛋白依赖性激酶 5 的抑制作用。

Explaining the inhibition of cyclin-dependent kinase 5 by peptides derived from p25 with molecular dynamics simulations and MM-PBSA.

机构信息

Department of Mechanical Engineering, National University of Singapore, 9 Engineering Drive 1, 117576 Singapore, Singapore.

出版信息

J Mol Model. 2010 Jan;16(1):1-8. doi: 10.1007/s00894-009-0514-1. Epub 2009 May 23.

DOI:10.1007/s00894-009-0514-1
PMID:19466465
Abstract

A cyclin-dependent kinase (CDK) 5 inhibitory peptide (CIP) from p25 was recently reported to inhibit CDK5/p25 activity in vitro but had no effect on endogenous cdc2 kinase activity. This may lead to a specific CDK5 inhibition strategy in the treatment of neurodegeneration. However, the mechanism of the inhibition remains unclear. In this work, molecular dynamics simulations and energy decomposition calculation models were set up to investigate the deregulation mechanisms of CIP on CDK5 activity. The results show that truncation of the N, and C terminals of p25 introduces important conformational changes into a hydrophobic pocket that is crucial for accommodating Ile153 on the activation loop of CDK5. In addition, such truncations lead to distortion and displacement of the activation loop and consequently affect binding of the substrate peptide. New inhibition sites for selectively inhibiting the activity of CDK5 are also suggested.

摘要

最近有报道称,来自 p25 的细胞周期蛋白依赖性激酶 (CDK) 5 抑制肽 (CIP) 可在体外抑制 CDK5/p25 的活性,但对内源性 cdc2 激酶活性没有影响。这可能为神经退行性疾病的治疗提供一种特异性 CDK5 抑制策略。然而,其抑制机制尚不清楚。在这项工作中,建立了分子动力学模拟和能量分解计算模型,以研究 CIP 对 CDK5 活性的调节机制。结果表明,p25 的 N 端和 C 端的截断会导致疏水性口袋发生重要的构象变化,该口袋对于容纳 CDK5 激活环上的 Ile153 至关重要。此外,这种截断会导致激活环的扭曲和位移,从而影响底物肽的结合。还提出了新的抑制位点,以选择性抑制 CDK5 的活性。

相似文献

1
Explaining the inhibition of cyclin-dependent kinase 5 by peptides derived from p25 with molecular dynamics simulations and MM-PBSA.用分子动力学模拟和 MM-PBSA 解释源自 p25 的肽对周期蛋白依赖性激酶 5 的抑制作用。
J Mol Model. 2010 Jan;16(1):1-8. doi: 10.1007/s00894-009-0514-1. Epub 2009 May 23.
2
Evaluation of the interaction of cyclin-dependent kinase 5 with activator p25 and with p25-derived inhibitor CIP.细胞周期蛋白依赖性激酶5与激活剂p25及p25衍生抑制剂CIP相互作用的评估。
J Comput Biol. 2010 May;17(5):707-21. doi: 10.1089/cmb.2009.0202.
3
An in silico approach for the discovery of CDK5/p25 interaction inhibitors.一种用于发现 CDK5/p25 相互作用抑制剂的计算方法。
Biotechnol J. 2011 Jul;6(7):871-81. doi: 10.1002/biot.201100139. Epub 2011 Jun 16.
4
Structural and dynamic determinants of ligand binding and regulation of cyclin-dependent kinase 5 by pathological activator p25 and inhibitory peptide CIP.配体结合的结构和动力学决定因素以及病理性激活剂 p25 和抑制肽 CIP 对细胞周期蛋白依赖性激酶 5 的调节作用。
J Mol Biol. 2010 Aug 20;401(3):478-92. doi: 10.1016/j.jmb.2010.06.040. Epub 2010 Jun 25.
5
Mechanism of CDK5 activation revealed by steered molecular dynamics simulations and energy calculations.定向分子动力学模拟和能量计算揭示的 CDK5 激活机制。
J Mol Model. 2010 Jun;16(6):1159-68. doi: 10.1007/s00894-009-0629-4. Epub 2009 Dec 15.
6
Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics.CDK5/p25和CDK2/细胞周期蛋白A动力学揭示的CDK5和CDK2激活的不同机制
J Biol Chem. 2006 Mar 17;281(11):7271-81. doi: 10.1074/jbc.M509699200. Epub 2006 Jan 9.
7
Structure and regulation of the CDK5-p25(nck5a) complex.CDK5-p25(nck5a)复合物的结构与调控
Mol Cell. 2001 Sep;8(3):657-69. doi: 10.1016/s1097-2765(01)00343-4.
8
A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells.一种源自细胞周期蛋白依赖性激酶激活剂(p35)的肽可特异性抑制转染细胞中的Cdk5活性及tau蛋白的磷酸化。
Eur J Biochem. 2002 Sep;269(18):4427-34. doi: 10.1046/j.1432-1033.2002.03133.x.
9
Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.源自细胞周期蛋白依赖性激酶5激活剂p35的肽,可特异性抑制细胞周期蛋白依赖性激酶5的失调活性。
Biotechnol J. 2007 Aug;2(8):978-87. doi: 10.1002/biot.200700057.
10
Molecular Recognition of PPARγ by Kinase Cdk5/p25: Insights from a Combination of Protein-Protein Docking and Adaptive Biasing Force Simulations.激酶Cdk5/p25对PPARγ的分子识别:来自蛋白质-蛋白质对接和自适应偏置力模拟相结合的见解
J Phys Chem B. 2015 Jul 2;119(26):8330-9. doi: 10.1021/acs.jpcb.5b04269. Epub 2015 Jun 19.

引用本文的文献

1
In silico design of potential Mcl-1 peptide-based inhibitors.基于 Mcl-1 肽的潜在抑制剂的计算机设计。
J Mol Model. 2024 Mar 18;30(4):108. doi: 10.1007/s00894-024-05901-8.
2
Effect of lipid saturation on amyloid-beta peptide partitioning and aggregation in neuronal membranes: molecular dynamics simulations.脂质饱和度对神经细胞膜中淀粉样β肽分配和聚集的影响:分子动力学模拟。
Eur Biophys J. 2019 Dec;48(8):813-824. doi: 10.1007/s00249-019-01407-x. Epub 2019 Oct 26.
3
The interaction of Munc 18 (p67) with the p10 domain of p35 protects in vivo Cdk5/p35 activity from inhibition by TFP5, a peptide derived from p35.

本文引用的文献

1
The activation and inhibition of cyclin-dependent kinase-5 by phosphorylation.通过磷酸化作用对细胞周期蛋白依赖性激酶5的激活与抑制。
Biochemistry. 2007 Sep 25;46(38):10841-51. doi: 10.1021/bi700890t. Epub 2007 Aug 22.
2
Significance of water molecules in the inhibition of cylin-dependent kinase 2 and 5 complexes.
J Chem Inf Model. 2007 Sep-Oct;47(5):1877-85. doi: 10.1021/ci700137c. Epub 2007 Aug 22.
3
Computational study of bindings of olive leaf extract (OLE) to HIV-1 fusion protein gp41.橄榄叶提取物(OLE)与HIV-1融合蛋白gp41结合的计算研究。
Munc 18(p67)与p35的p10结构域之间的相互作用可在体内保护Cdk5/p35活性免受TFP5(一种源自p35的肽)的抑制。
Mol Biol Cell. 2016 Nov 1;27(21):3221-3232. doi: 10.1091/mbc.E15-12-0857. Epub 2016 Sep 14.
4
Molecular dynamic simulations reveal the mechanism of binding between xanthine inhibitors and DPP-4.分子动力学模拟揭示了黄嘌呤抑制剂与 DPP-4 之间结合的机制。
J Mol Model. 2014 Feb;20(2):2075. doi: 10.1007/s00894-014-2075-1. Epub 2014 Jan 31.
5
Molecular dynamic simulations give insight into the mechanism of binding between 2-aminothiazole inhibitors and CDK5.分子动力学模拟深入了解 2-氨基噻唑抑制剂与 CDK5 之间结合的机制。
J Mol Model. 2013 Jun;19(6):2635-45. doi: 10.1007/s00894-013-1815-y. Epub 2013 Mar 23.
6
Structural and dynamic determinants of ligand binding and regulation of cyclin-dependent kinase 5 by pathological activator p25 and inhibitory peptide CIP.配体结合的结构和动力学决定因素以及病理性激活剂 p25 和抑制肽 CIP 对细胞周期蛋白依赖性激酶 5 的调节作用。
J Mol Biol. 2010 Aug 20;401(3):478-92. doi: 10.1016/j.jmb.2010.06.040. Epub 2010 Jun 25.
FEBS Lett. 2007 Jun 12;581(14):2737-42. doi: 10.1016/j.febslet.2007.05.029. Epub 2007 May 21.
4
Molecular dynamics simulations on the inhibition of cyclin-dependent kinases 2 and 5 in the presence of activators.在激活剂存在的情况下对细胞周期蛋白依赖性激酶2和5抑制作用的分子动力学模拟
J Comput Aided Mol Des. 2006 Jun;20(6):395-404. doi: 10.1007/s10822-006-9081-z. Epub 2006 Oct 13.
5
Study of the inhibition of cyclin-dependent kinases with roscovitine and indirubin-3'-oxime from molecular dynamics simulations.基于分子动力学模拟研究罗斯考维汀和靛玉红-3'-肟对细胞周期蛋白依赖性激酶的抑制作用
J Mol Model. 2007 Jan;13(1):79-89. doi: 10.1007/s00894-006-0127-x. Epub 2006 Jun 13.
6
Exploiting structural principles to design cyclin-dependent kinase inhibitors.利用结构原理设计细胞周期蛋白依赖性激酶抑制剂。
Biochim Biophys Acta. 2005 Dec 30;1754(1-2):58-64. doi: 10.1016/j.bbapap.2005.08.019. Epub 2005 Sep 12.
7
Some insights into the stereochemistry of inhibition of macrophage migration inhibitory factor with 2-fluoro-p-hydroxycinnamate and its analogues from molecular dynamics simulations.基于分子动力学模拟对2-氟对羟基肉桂酸及其类似物抑制巨噬细胞迁移抑制因子的立体化学的一些见解。
J Med Chem. 2005 Nov 17;48(23):7208-14. doi: 10.1021/jm050562z.
8
The therapeutic potential of targeting the cell cycle.靶向细胞周期的治疗潜力。
Expert Opin Investig Drugs. 1998 Jun;7(6):865-87. doi: 10.1517/13543784.7.6.865.
9
Mechanism of CDK5/p25 binding by CDK inhibitors.CDK抑制剂与CDK5/p25结合的机制。
J Med Chem. 2005 Feb 10;48(3):671-9. doi: 10.1021/jm049323m.
10
Protein kinase inhibitors: insights into drug design from structure.蛋白激酶抑制剂:基于结构的药物设计见解
Science. 2004 Mar 19;303(5665):1800-5. doi: 10.1126/science.1095920.